On ECHEMI
Home > Drugs > Cancerous neuromyopathy
Cancerous neuromyopathy
Cancerous neuromyopathy refers to a disease of cancerous neuromuscular lesions and functional disorders caused by non-tumor direct invasion in patients with malignant tumors. In other words, it is a unique neurological, psychiatric and myopathic lesions that are unrelated to cancer metastasis and infiltration, but occur before or after the onset of symptoms of the primary cancer lesions.
  • Site of disease:

    Peripheral nervous system Muscles Whole body
  • Infectious :

    Not contagious
  • Frequent population:

    Most common in lung cancer, followed by breast cancer
  • Related symptoms:

    Numbness in the limbs deep sensory impairment involuntary movement facial weakness numbness, pain or strange sensation in the distal limbs
  • Concurrent disease:

Related Drugs
Riluzole Tablets
Indication: For the treatment of patients with amyotrophic lateral sclerosis, it can prolong survival and/or delay the need for tracheotomy.
Manufacturer:

Jiangsu Nhwa Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.